Daratumumab for a Patient With Refractory Antineutrophil Cytoplasmatic Antibody-Associated Vasculitis.
JAMA Intern Med
; 183(6): 615-618, 2023 06 01.
Article
in En
| MEDLINE
| ID: mdl-37036724
This case reports on a patient with antineutrophil cytoplasmatic antibodyassociated vasculitis and severe pulmonary and cutaneous involvement who received conventional therapy that failed and who was rescued by daratumumab therapy.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Type of study:
Diagnostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
JAMA Intern Med
Year:
2023
Document type:
Article
Affiliation country:
Germany